Abdominal wall desmoid tumors associated with pregnancy: Current concepts

Expert Review of Anticancer Therapy

Volumn 9, Issue 11, 2009, Pages 1675-1682

  Johner, Amanda ^b   Tiwari, Pari ^b   Zetler, Peter ^b   Wiseman, Sam M ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Desmoid tumor; Pregnancy; Soft tissue tumors

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; DOXORUBICIN; IMATINIB; METHOTREXATE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TAMOXIFEN; VINBLASTINE;

ABDOMINAL FIBROMATOSIS; ABDOMINAL SURGERY; ADENOMATOUS POLYP; ADJUVANT THERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CESAREAN SECTION; CHROMOSOME ABERRATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DISEASE COURSE; ECHOGRAPHY; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PROGRESSION FREE SURVIVAL; PUERPERIUM; RECURRENCE RISK; REVIEW; SECOND TRIMESTER ABORTION; SURVIVAL TIME; THIRD TRIMESTER PREGNANCY; TUMOR GROWTH; TUMOR VOLUME; VAGINAL DELIVERY;

ABDOMINAL WALL; CHEMOTHERAPY, ADJUVANT; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RADIOTHERAPY, ADJUVANT;

EID: 71949084274     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.98     Document Type: Review

References (78)

1. Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor: incidence, sex, age and anatomic distribution in the Finnish population. Am. J. Clin. Pathol. 77, 665-673 (1982). (Pubitemid 12073161)
2. Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A et al. Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis. Clin. Gastroenterol. Hepatol. 6, 215-219(2008). • Large cohort study that found no association between female sex or pregnancy and desmoid development in familial adenomatous polyposis coli (FAP) patients. (Pubitemid 351172943)
3. Lewis JJ, Boland PJ, Leung DHY, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann. Surg. 6, 866-873 (1999).
4. Gansar GF, Markowitz IP, Cerise EJ. Thirty years of experience with desmoid tumors at Charity Hospital. Am. Surg. 53(6), 318-319 (1987).
5. Galeotti F, Facci E, Bianchini E. Desmoid tumour involving the abdominal rectus muscle: report of a case. Hernia 10, 278-281 (2006). (Pubitemid 43853607)
6. De Wever I, Dal Cin P, Fletcher CD et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Chromosomes and morphology. Mod. Pathol. 13, 1080-1085 (2000). (Pubitemid 30796748)
7. Fletcher JA, Naeem R, Xiao S, Corson JM. Chromosome aberrations in desmoid tumors: trisomy 8 may be a predictor of recurrence. Cancer Genet. Cytogenet. 63, 527-529 (1995).
8. Hosalkar HS, Fox EJ, Delaney T, Torbet JT, Ogilvie CM, Lackman RD. Desmoid tumors and current status of management. Orthop. Clin. North Am. 37, 53-63 (2006). (Pubitemid 41719086)
9. Tejpar S, Nollet F, Li C et al. Predominance of b-catenin mutations and β-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18, 6615-6620 (1999).
10. Heinrich MC, McArthur GA, Demetri GD et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J. Clin. Oncol. 24, 1195-1203 (2006).
11. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and β-catenin in the aetiology of aggressive fibromatosis. Eur. J. Surg. Oncol. 35(1), 3-10 (2009). • Discusses the neoplastic nature of desmoid tumors (DTs) and the role of the adenomatous polyposis coli (APC) and β-catenin signaling cascade in driving the development and progression of the disease.
12. Cheon SS, Cheah AY, Turley S et al. β-catenin stabilization dysregulates mesenchymal cell proliferation, motility and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc. Natl Acad. Sci. USA 99, 6973-6978 (2002). (Pubitemid 34526242)
13. Cheon S, Poon R, Yu C et al. Prolonged β-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab. Invest. 85, 416-425 (2005). (Pubitemid 40333158)
14. Merchant NB, Lewis JJ, Woodruff JM, Leung DHY, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86, 2045-2052 (1999).
15. Tejpar S, Michils G, Denys H et al. Analysis of Wnt/B catenin signalling in desmoid tumors. Acta Gastroenterol. Belg. 68, 5-9 (2005). (Pubitemid 40477417)
16. Hayry P, Scheinin TM. The desmoid (Reitamo) syndrome: aetiology, manifestations, pathogenesis and treatment. Curr. Probl. Surg. 25, 227-314 (1988). (Pubitemid 18142945)
17. Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am. J. Surg. 151, 230-237 (1986). (Pubitemid 16107305)
18. Posner MC, Shui MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF. The desmoid tumor: not a benign disease. Arch. Surg. 124, 191-196 (1989).
19. Brasfield RD, Das Gupta TK. Desmoid tumors of the anterior abdominal wall. Arch. Surg. 65, 241-246 (1969).
20. Lopez R, Kemalyan N, Moseley HS, Dennis D, Vetto RM. Problems in diagnosis and management of desmoid tumors. Am. J. Surg. 159, 450-453 (1990). (Pubitemid 20160997)
21. McKinnon JG, Neifeld JP, Kay S, Parker GA, Foster WC, Lawrence W. Management of desmoid tumors. Surg. Gynecol. Obstet. 169, 104-106 (1989).
22. Enzinger FM, Weiss SW. Soft Tissue Tumors (3rd Edition). Mosby Year Book Inc. MO, USA 201 (1995).
23. De Cian F, Delay E, Rudigoz RC, Ranchere D, Rivoire M. Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management. Gynecol. Oncol. 75, 145-148 (1999). (Pubitemid 29477818)
24. Durkin AJ, Korkolis DP, Al-Saif O, Zervos EE. Full-term gestation and transvaginal delivery after wide resection of an abdominal desmoid tumour during pregnancy. J. Surg. Oncol. 89, 86-90 (2005). (Pubitemid 40189815)
25. Kunieda K, Saji S, Tanaka Y, Katoh M, Fukada D, Shimokawa K. An abdominal desmoid tumour involving the xyphoid and costal chondrium associated with pregnancy: report of a case. Surg. Today 29, 927-930 (1999). (Pubitemid 29459550)
26. Leppert PC. Proliferation and apoptosis of fibroblasts and smooth muscle cells in rat uterine cervix throughout gestation and the effect of the antiprogesterone onapristone. Am. J. Obstet. Gynecol. 178, 713-725 (1998).
27. Tonelli F, Valanzano R, Brandi ML. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study. Surgery 115, 473-479 (1994). (Pubitemid 24123636)
28. Alman BA, Naber SP, Terek RM, Jiranek WA, Goldberg MJ, Wolfe HJ. Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J. Orthop. Res. 13, 67-77 (1995).
29. Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur. J. Cancer Clin. Oncol. 22, 583-587 (1986).
30. Hayry P, Reitamo JJ, Totterman S, Hopfner-Hallikainen D, Sivula A. The desmoid tumor: analysis of factors possibly contributing to the etiology and growth behaviour. Am. J. Clin. Pathol. 77, 674-680 (1982). (Pubitemid 12073162)
31. Serpell JW, Tang HS, Donnovan M. Desmoid tumors. Aus. NZ J. Surg. 69, 782-784 (1999).
32. Kulaylat MN, Karakousis CP, Keaney CM, McCorvey D, Bem J, Ambrus JL. Desmoid tumor: a pleomorphic lesion. Eur. J. Surg. Oncol. 25, 487-497 (1999).
33. Way JC, Culham BA. Desmoid tumor. The risk of recurrent or new disease with subsequent pregnancy: a case report. Can. J. Surg. 42, 151-154 (1999).
34. Cohen MD. Imaging of Children with Cancer. Mosby Year Book Inc., MO, USA 339-342 (1992).
35. Winer-Muram HT, Bowman LC, Parham D. Intrathoracic desmoid tumor: CT and MRI appearance. South Med. J. 87, 1007-1009 (1994). (Pubitemid 24312015)
36. Quinn SF, Erickson SJ, Dee PM et al. MR imaging in fibromatosis: results in 26 patients with pathologic correlation. AJR Am. J. Roentgenol. 156, 539-542 (1991).
37. Vandevenne JE, De Schepper AM, De Beuckeleer L et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur. Radiol. 7, 1013-1019 (1997). (Pubitemid 127537123)
38. Brancato G, Donati M, Privitera A, Gandolfo L, Cardi F. Current approach in the treatment of desmoid tumours of the abdominal wall. Chir. Ital. 53, 697-704 (2001).
39. Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G. Imaging of intra and extra-abdominal desmoid tumours. Radiographics 11, 959-968 (1991).
40. Molelekwa V, Fernandes H, Kerin M, Geary M. Conservative management of a desmoid tumour in pregnancy. J. Obstet. Gynecol. 24(6), 700-708 (2004).
41. Shields CJ, Winter DC, Kirwan WO, Redmond HP. Desmoid tumours. Eur. J. Surg. Oncol. 27(8), 701-706 (2001).
42. Hatzimarkou A, Filippou D, Papadopoulos V et al. Desmoid tumor in Gardner's Syndrome presented as acute abdomen. World J. Surg. Oncol. 4, 18-23 (2006).
43. Brueckl WM, Ballhausen WG, Förtsch T et al. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis. Colon Rectum 48(6), 1275-1281 (2005). • Study that performed mutation screening in non-FAP-associated DTs and found no translational stop mutations typical for FAP in their APC gene. They concluded that patients with sporadic DTs and no clinical signs of FAP do not need to undergo APC gene testing. (Pubitemid 40897876)
44. Sakorafas GH, Nissotakis C, Peros G. Abdominal desmoid tumors. Surg. Oncol. 16, 131-142 (2007).
45. Latchford AR, Sturt NJH, Neale K, Rogers PA, Phillips RKS. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br. J. Surg. 93, 1258-1264 (2006). (Pubitemid 44547026)
46. Lasagna B, Botto-Micca F, Resegotti A, Garino M. Abdominal desmoid tumor. Minerva Chir. 48, 163-166 (1993).
47. Kiel KD, Suit HD. Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer 54, 2051-2054 (1984).
48. Gronchi A, Casali PG, Mariani L et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J. Clin. Oncol. 21, 1390-1397 (2003). (Pubitemid 46606421)
49. Leithner A, Gapp M, Leithner K et al. Margins in extra-abdominal desmoid tumors: a comparative analysis. J. Surg. Oncol. 86, 152-156 (2004). • One of the first studies to challenge the standard treatment approach to DTs of wide surgical excision. They report that 27-30% of patients with extra-abdominal DTs and positive surgical margins do not have tumor recurrence.
50. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J. Clin. Oncol. 17, 158-167 (1999). (Pubitemid 29022389)
51. Rohrich RJ, Lowe JB, Hackney FL, Bowman JL, Hobar PC. An algorithm for abdominal wall reconstruction. Plast. Reconstr. Surg. 105, 202-216 (2000).
52. Sutton RJ, Thomas JM. Desmoid tumors of the anterior abdominal wall. Eur. J. Surg. Oncol. 25, 398-400 (1999).
53. Carneiro C, Hurtubis C, Singh M, Robinson W. Desmoid tumors of the right rectus abdominus muscle in postpartum women. Arch. Gynecol. Obstet. 279(6), 869-873 (2009).
54. Stoeckle E, Coindre JM, Longy M et al. A critical analysis of treatment strategies in desmoid tumors: a review of a series of 106 cases. Eur. J. Surg. Oncol. 35(2), 129-134 (2009). • Study that highlighted the indolent nature of DTs and promoted a wait-and-see treatment approach for selected patients.
55. Ballo MT, Zagars GK, Pollack A. Radiation therapy in the management of desmoid tumors. Int. J. Radiat. Oncol. Biol. Phys. 42, 1007-1014 (1998). (Pubitemid 29004142)
56. Spear MA, Jennings LC, Mankin HJ et al. Individualizing management of aggressive fibromatoses. Int. J. Radiat. Oncol. Biol. Phys. 40, 637-645 (1998).
57. Bataini JP, Belloir C, Mazarbraud A et al. Desmoid tumors in adults: the role of radiotherapy in their management. Am. J. Surg. 155, 754-760 (1988). (Pubitemid 18154282)
58. Pritchard DJ, Nascimento AG, Petersen IA. Local control of extraabdominal desmoid tumors. J. Bone Joint Surg. 78, 848-854 (1996).
59. Sherman NE, Romsdahl M, Evans H, Zagars G, Oswald MJ. Desmoid tumors: a 20-year radiotherapy experience. Int. J. Radiat. Oncol. Biol. Phys. 19, 37-40 (1990). (Pubitemid 20239782)
60. Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M. The role of radiation therapy in the management of desmoid tumors. Strahlenther Onkol. 178, 78-83 (2002). (Pubitemid 34135514)
61. O'Dea FJ, Wunder J, Bell RS, Griffin AM, Catton C, O'Sullivan B. Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin. Orthop. Relat. Res. 415, 19-24 (2003). (Pubitemid 37329035)
62. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. Cancer 88, 1517-1523 (2000).
63. Baumert BG, Spahr MO, Von Hochstetter A et al. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat. Oncol. 2, 12 (2007).
64. Lev D, Kotilingam D, Wei C et al. Optimizing treatment of desmoid tumors. J. Clin. Oncol. 25, 1785-1791 (2007).
65. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100, 612-620 (2004). (Pubitemid 38128287)
66. Waddell WR, Garner RE. Indomethacin and ascorbate inhibit desmoid tumors. J. Surg. Oncol. 15, 85-90 (1980).
67. Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer 67, 1443-1446 (1991).
68. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J. Surg. Oncol. 97, 554-558 (2008).
69. Clark SK, Phillips RKS. Desmoid in familial adenomatous polyposis. Br. J. Surg. 83, 1494-1504 (1996).
70. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 72, 3244-3247 (1993).
71. Gega M, Yanagi H, Yoshikawa R et al. Successful chemo-therapeutic modality of doxorubin plus decarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J. Clin. Oncol. 24, 102-105 (2006). (Pubitemid 46630500)
72. Kotiligam D, Lazar AJF, Pollock RE et al. Desmoid tumor: a disease opportune for molecular insights. Histol. Histopathol. 23, 117-126 (2008).
73. Church JM. Desmoid tumors in patients with familial adenomatous polyposis. Semin. Colon Rectum Surg. 6, 29-32 (1995).
74. Bonvalot S, Eldweny H, Haddad V et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur. J. Surg. Oncol. 34(4), 462-468 (2008).
75. Ezra Y, Krausz MM, Rivkind A, Anteby SO. Successful pregnancy and normal delivery with Marlex mesh replacement of the abdominal wall. Am. J. Obstet. Gynecol. 162, 97-99 (1990). (Pubitemid 20055430)
76. Firoozmand E, Prager E. Pelvic desmoid tumor: threat to mother and fetus. Am. Surg. 67(12), 1213-1215 (2001). (Pubitemid 33738195)
77. Aaen V, Cowan L, Sakala EP, Small ML. Prolonged parenteral meperidine analgesia during pregnancy during pregnancy for pain from an abdominal wall mesh graft. Obstet. Gynecol. 82, 721-722 (1993). (Pubitemid 23276518)
78. Caldwell EH. Desmoid tumor: musculoaponeurotic fibrosis of the abdominal wall. Surgery 79, 104-106 (1976).